EA inhibits the high-mobility group Box 1 (HMGB1)/NLRP3/NF-κB pathway, and HMGB1 inhibition enhances the anti-inflammatory effect of EA on DN by suppressing the NLRP3/NF-κB pathway [57]. This evidence concerns the gene NFKB1 and liver dysplastic nodule.